GlassScriptPhysician profile
George Robert Matcuk
NPI 1972721751
$44,324.48
in general payments reported to CMS, 2019-2025
7 companies · $5,025 in 2025
The $5,025 reported for 2025 was more than what 95% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,920 · 2020: $16K · 2021: $8,250 · 2022: $3,400 · 2023: $47.84 · 2024: $5,932 · 2025: $5,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,800.00 |
| Food and Beverage | $204.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Canon Medical Systems USA, INC. | $43,950.00 | 2019-2025 | Vantage Galan 3t, Toshiba Superconducting Mri System Vantage Titan |
| Siemens Medical Solutions USA, INC. | $221.18 | 2019-2024 | Artis Icono Biplane |
| Avanos Medical | $42.67 | 2024-2025 | Generator, Coolief* Cooled Radiofrequency |
| Ge Healthcare | $38.39 | 2025 | |
| Bard Peripheral Vascular, INC. | $27.07 | 2023 | Trek |
| Angiodynamics, INC. | $24.40 | 2024 | Nanoknife |
| Checkpoint Surgical, INC | $20.77 | 2023 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Matcuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.